Literature DB >> 16236485

Differential role of lipid rafts in the functions of CD4+ and CD8+ human T lymphocytes with aging.

Anis Larbi1, Gilles Dupuis, Abdelouahed Khalil, Nadine Douziech, Carl Fortin, Tamàs Fülöp.   

Abstract

Lipid rafts are critical to the assembly of the T-cell receptor (TCR) signaling machinery. It is not known whether lipid raft properties differ in CD4+ and CD8+ T cells and whether there are age-related differences that may account in part for immune senescence. Data presented here showed that time-dependent interleukin-2 (IL-2) production was different between CD4+ and CD8+ T cells. The defect in IL-2 production by CD4+ T cells was not due to lower levels of expression of the TCR or CD28. There was a direct correlation between the activation of p56(Lck) and LAT and their association/recruitment with the lipid raft fractions of CD4+ and CD8+ T cells. p56Lck, LAT and Akt/PKB were weakly phosphorylated in lipid rafts of stimulated CD4+ T cells of elderly as compared to young donors. Lipid rafts undergo changes in their lipid composition (ganglioside M1, cholesterol) in CD4+ and CD8+ T cells of elderly individuals. This study emphasizes the differential role of lipid rafts in CD4+ and CD8+ T-cell activation in aging and suggests that the differential localization of CD28 may explain disparities in response to stimulation in human aging.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16236485     DOI: 10.1016/j.cellsig.2005.08.016

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  36 in total

1.  The role of cholesterol in UV light B-induced apoptosis.

Authors:  Kimberly S George; Walid Elyassaki; Qiong Wu; Shiyong Wu
Journal:  Photochem Photobiol       Date:  2011-12-16       Impact factor: 3.421

Review 2.  The immune system in the aging human.

Authors:  Paulina Dominika Rymkiewicz; Yi Xiong Heng; Anusha Vasudev; Anis Larbi
Journal:  Immunol Res       Date:  2012-09       Impact factor: 2.829

3.  Predicting cytotoxic T-cell age from multivariate analysis of static and dynamic biomarkers.

Authors:  Catherine A Rivet; Abby S Hill; Hang Lu; Melissa L Kemp
Journal:  Mol Cell Proteomics       Date:  2010-12-30       Impact factor: 5.911

Review 4.  Intracellular signalling pathways: targets to reverse immunosenescence.

Authors:  T Fulop; J M Witkowski; A Le Page; C Fortin; G Pawelec; A Larbi
Journal:  Clin Exp Immunol       Date:  2016-08-03       Impact factor: 4.330

Review 5.  Aging of the immune system: Focus on inflammation and vaccination.

Authors:  Marcello Pinti; Victor Appay; Judith Campisi; Daniela Frasca; Tamas Fülöp; Delphine Sauce; Anis Larbi; Birgit Weinberger; Andrea Cossarizza
Journal:  Eur J Immunol       Date:  2016-10       Impact factor: 5.532

Review 6.  Expansions of NK-like αβT cells with chronologic aging: novel lymphocyte effectors that compensate for functional deficits of conventional NK cells and T cells.

Authors:  Abbe N Vallejo; Robert G Mueller; David L Hamel; Amanda Way; Jeffrey A Dvergsten; Patricia Griffin; Anne B Newman
Journal:  Ageing Res Rev       Date:  2010-10-12       Impact factor: 10.895

7.  Age-related changes in lck-Vav signaling pathways in mouse CD4 T cells.

Authors:  Gonzalo G Garcia; Richard A Miller
Journal:  Cell Immunol       Date:  2009-06-06       Impact factor: 4.868

8.  Calorie restriction enhances T-cell-mediated immune response in adult overweight men and women.

Authors:  Tanvir Ahmed; Sai Krupa Das; Julie K Golden; Edward Saltzman; Susan B Roberts; Simin Nikbin Meydani
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2009-07-28       Impact factor: 6.053

9.  Immunomodulatory role of high-density lipoproteins: impact on immunosenescence.

Authors:  Anis Larbi; Carl Fortin; Gilles Dupuis; Hicham Berrougui; Abdelouahed Khalil; Tamas Fulop
Journal:  Age (Dordr)       Date:  2014-09-13

Review 10.  Low zinc status: a new risk factor for pneumonia in the elderly?

Authors:  Junaidah B Barnett; Davidson H Hamer; Simin N Meydani
Journal:  Nutr Rev       Date:  2010-01       Impact factor: 7.110

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.